| Identifier | Protein names | Gene names | Cross reference refseq | Length | Species |
| A4ZLF7 | NADH-ubiquinone oxidoreductase chain 2; EC 1.6.5.3; | ND2; | NULL | 347 | human |
| F1DSG4 | Aquaporin 4 transcript variant a; Aquaporin 4, isoform CRA_a; | AQP4; | NP_001641.1; | 323 | human |
| D7RIH8 | MHC class II antigen; | HLA-DRB1; | NP_002115.2; | 266 | human |
| J7HKD4 | NADH-ubiquinone oxidoreductase chain 5; EC 1.6.5.3; | ND5; | NULL | 603 | human |
| E5KND5 | Elongation factor G, mitochondrial; EF-Gmt; Elongation factor G 1, mitochondrial; Elongation factor G1; | GFM1; EFG1; | NP_079272.4; | 751 | human |
| Q54A64 | MHC class I antigen; Major histocompatibility complex, class I, B; | HLA-B; | NULL | 362 | human |
| F8VX74 | ATP-sensitive inward rectifier potassium channel 15; Fragment; | KCNJ15; | NULL | 48 | human |
| I6LJZ9 | BCL2L12 protein isoform 8; Bcl-2-like protein 12; | BCL2L12; | NP_001269450.1; | 193 | human |
| D1CS34 | Toll-like receptor; | TLR1; | NULL | 786 | human |
| Q762C7 | HUp49; cDNA FLJ40082 fis, clone TESTI2002282, highly similar to Calpain-3 (EC 3.4.22.-); | CAPN3; | NULL | 426 | human |
| Q9B2W5 | NADH-ubiquinone oxidoreductase chain 4; EC 1.6.5.3; | ND4; NADH4; | NULL | 459 | human |
| A0A087WT42 | Solute carrier family 2, (Facilitated glucose transporter) member 8, isoform CRA_c; Solute carrier family 2, facilitated glucose transporter member 8; | SLC2A8; | NULL | 314 | human |
| D3DS91 | A kinase (PRKA) anchor protein 6, isoform CRA_b; | AKAP6; | NULL | 2077 | human |
| G3XAJ6 | Raft-linking protein, isoform CRA_c; Raftlin; | RFTN1; RAFTLIN; | NULL | 542 | human |
| E3NZD8 | KIR2DL3; | KIR2DL3; | NP_056952.2; | 341 | human |
| Q9UEL6 | Myelin protein zero-like protein 1; Fragment; | MPZL1; | NULL | 183 | human |
| B3KQJ9 | cDNA FLJ46665 fis, clone TRACH3007277, highly similar to Golgi phosphoprotein 3; cDNA FLJ90596 fis, clone PLACE1001229, highly similar to Golgi phosphoprotein 3; | NULL | NULL | 100 | human |
| Q0VV07 | ATP synthase subunit a; | ATP6; | NULL | 226 | human |
| F2Z3L8 | V-type proton ATPase subunit S1; | ATP6AP1; | NULL | 134 | human |
| Q8N450 | FSD1-like protein; FSD1L protein; | FSD1L; | NP_001138785.1;NP_001274120.1;NP_001274121.1; | 311 | human |
UrgentMab™: Thinking is cheap. Test your ideas, fast and furious. |
 |
|
Custom monoclonal antibody in one month. As low as $200-300 per antigen. |
|
A product of Absolution |
|
SEAL™: Today's out-of-reach protein targets made accessible. |
|
|
Same budget, 5-10 times more antibodying SEAL your protein. Successes too. |
|
A product of Absolution |
|
PETAL™: Fast and high throughput antibody discover platform. |
 |
|
Deliver customized antibody in two weeks at price of category antibody Proteome-scale antibody discovery for any organism or proteome Biomarker discovery for biological processes or human diseases |
|
A product of Absolution |
|
AbFocus™: Target all the modification sites of your protein, affordably. |
|
|
Test them with a panel of AbFocus antibodies It is so affordable that you can focus on testing, not guessing |
|
A product of Absolution |
Mabome™: Catch the antibody gold rush.? Lead the next omics revolution. |
|
|
First-ever antibody proteomics technology. High quality monoclonal antibodies for your favorite proteome. As low as $19/monoclonal antibody |
|
A product of Absolution |
AbTarget™: Performing antibody for your proteome.? Guaranteed |
|
|
Fast, efficient monoclonal antibody development for proteins in a proteome Pay for successful antibodies only |
|
A product of Absolution |
AbProfile™: Discover an array of unbiased differences.? Proteome-scale |
|
|
50,000 monoclonal antibodies on an array.100 times more content. Differential profiling thousands of cell surface receptorsand plasma proteins |
|
A product of Absolution |
|
SMAL™:?All big things have a SMAL beginning. |
|
|
High success rate for mAb generation Deliver a panel of high affinity mAbs Flexible and optional fee structure for minimizing risks |
|
A product of Absolution |
AbX™: X=anything.? Find your antibody within |
|
|
currently 7species.?200,000 mAbs.70,000 proteins 3 new organisms are being AbXed/day Pre-made anti-peptide mAbs against all proteins in nature. |
|
A product of AbStore |
AbStop™: The last stop of antibody development. The most successful stop. |
|
|
Pre-designed antibody packages against high value targets The most aggressive and comprehensive protein targeting Best for diagnostics and therapeutic antibody development |
|
A product of AbStore |